Anna Biernacka
Impact in
-
- Cardiac Fibrosis and Remodeling
- Cardiovascular Function and Risk Factors
- Oncology top 5%
- Cancer-related Molecular Pathways
Papers in
-
- DNA Repair Mechanisms 6
- Genomics and Chromatin Dynamics 4
- CRISPR and Genetic Engineering 4
- Advanced biosensing and bioanalysis techniques 3
- Oncology 9
- Cancer-related Molecular Pathways 7
- Co-authors
- Nikolaos G. Frangogiannis (5 shared papers)Marcin Dobaczewski (4 shared papers)Maga Rowicka (7 shared papers)Krzysztof Ginalski (7 shared papers)Magdalena Skrzypczak (6 shared papers)Khandan Keyomarsi (7 shared papers)Carlos Gonzalez‐Quesada (3 shared papers)Kelly K. Hunt (6 shared papers)
- Journals
- Clinical Cancer Research (3 papers)Cancer Research (3 papers)Nature Communications (2 papers)Pediatric Nephrology (2 papers)Diagnostic Cytopathology (2 papers)
- Partner nations
- United StatesPolandFrance
In The Last Decade
Anna Biernacka
40 papers receiving 2.8k citations
Anna Biernacka's Hit Papers
Peers
Comparison fields: 5 of 114
- Cardiology and Cardiovascular Medicine 523
- Oncology 523
- Molecular Biology 1.4k
- Cancer Research 251
- Pulmonary and Respiratory Medicine 446
Countries citing papers authored by Anna Biernacka
This map shows the geographic impact of Anna Biernacka's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anna Biernacka with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anna Biernacka more than expected).
Fields of papers citing papers by Anna Biernacka
This network shows the impact of papers produced by Anna Biernacka. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anna Biernacka. The network helps show where Anna Biernacka may publish in the future.
Co-authors
The 25 scholars most cited alongside Anna Biernacka, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 40 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | TGF-β signaling in fibrosis Hit paper breakdown → | 2011 | 953 |
| 2 | Aging and Cardiac Fibrosis. | 2011 | 321 |
| 3 | 2018 | 226 | |
| 4 | 2017 | 196 | |
| 5 | 2020 | 139 | |
| 6 | 2011 | 115 | |
| 7 | 2013 | 112 | |
| 8 | 2015 | 109 | |
| 9 | 2016 | 90 | |
| 10 | 2016 | 50 | |
| 11 | 2016 | 50 | |
| 12 | 2010 | 50 | |
| 13 | 2012 | 49 | |
| 14 | 2010 | 47 | |
| 15 | 2010 | 41 | |
| 16 | 2019 | 39 | |
| 17 | 2013 | 38 | |
| 18 | 2018 | 36 | |
| 19 | 2010 | 31 | |
| 20 | 2020 | 29 |
About Anna Biernacka
Anna Biernacka is a scholar working on Molecular Biology, Oncology, Pulmonary and Respiratory Medicine, Nephrology and Surgery, having authored 40 papers that have together received 2.9k indexed citations. Recurring topics across this work include Cancer-related Molecular Pathways (7 papers), DNA Repair Mechanisms (6 papers), Genomics and Chromatin Dynamics (4 papers), CRISPR and Genetic Engineering (4 papers), Microtubule and mitosis dynamics (3 papers), Renal Diseases and Glomerulopathies (3 papers), Advanced biosensing and bioanalysis techniques (3 papers) and Chronic Kidney Disease and Diabetes (2 papers). The work is most often cited by research in Cardiology and Cardiovascular Medicine (523 citations), Oncology (523 citations), Molecular Biology (1.4k citations), Cancer Research (251 citations) and Pulmonary and Respiratory Medicine (446 citations). Anna Biernacka has collaborated with scholars based in United States, Poland and France. Frequent co-authors include Nikolaos G. Frangogiannis, Marcin Dobaczewski, Maga Rowicka, Krzysztof Ginalski, Magdalena Skrzypczak, Khandan Keyomarsi, Carlos Gonzalez‐Quesada, Kelly K. Hunt, Coline Arnould and Jason S. Iacovoni. Their work appears in journals such as Clinical Cancer Research, Cancer Research, Nature Communications, Pediatric Nephrology and Diagnostic Cytopathology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.